International Biotechnology Trust’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-151,800
| Closed | -$1.64M | – | 83 |
|
|
2022
Q1 | $1.64M | Buy |
151,800
+57,000
| +60% | +$615K | 0.37% | 45 |
|
|
2021
Q4 | $2.77M | Buy |
94,800
+73,000
| +335% | +$2.13M | 0.62% | 38 |
|
|
2021
Q3 | $555K | Hold |
21,800
| – | – | 0.13% | 58 |
|
|
2021
Q2 | $763K | Hold |
21,800
| – | – | 0.2% | 55 |
|
|
2021
Q1 | $888K | Hold |
21,800
| – | – | 0.23% | 49 |
|
|
2020
Q4 | $944K | Hold |
21,800
| – | – | 0.26% | 45 |
|
|
2020
Q3 | $1.2M | Buy |
21,800
+12,000
| +122% | +$662K | 0.39% | 39 |
|
|
2020
Q2 | $652K | Hold |
9,800
| – | – | 0.22% | 49 |
|
|
2020
Q1 | $498K | Sell |
9,800
-13,300
| -58% | -$676K | 0.23% | 52 |
|
|
2019
Q4 | $1.84M | Buy |
23,100
+4,600
| +25% | +$366K | 0.66% | 34 |
|
|
2019
Q3 | $897K | Sell |
18,500
-9,500
| -34% | -$461K | 0.41% | 43 |
|
|
2019
Q2 | $1.47M | Hold |
28,000
| – | – | 0.55% | 44 |
|
|
2019
Q1 | $1.48M | Buy |
+28,000
| New | +$1.48M | 0.55% | 48 |
|
|
2017
Q3 | – | Sell |
-20,500
| Closed | -$561K | – | 67 |
|
|
2017
Q2 | $561K | Sell |
20,500
-37,500
| -65% | -$1.03M | 0.21% | 59 |
|
|
2017
Q1 | $2.13M | Buy |
+58,000
| New | +$2.13M | 0.82% | 31 |
|